|
ZNHIT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.309800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.442560E-01 |
| Normal-vs-Stage2 |
9.399300E-03 |
| Normal-vs-Stage3 |
3.513800E-01 |
| Normal-vs-Stage4 |
9.207000E-01 |
| Stage1-vs-Stage2 |
4.976200E-02 |
| Stage1-vs-Stage3 |
6.894000E-01 |
| Stage1-vs-Stage4 |
2.153400E-01 |
| Stage2-vs-Stage3 |
3.797600E-02 |
| Stage2-vs-Stage4 |
1.309720E-02 |
| Stage3-vs-Stage4 |
4.636400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.048200E-01 |
| Normal-vs-AfricanAmerican |
8.805400E-01 |
| Normal-vs-Asian |
5.038200E-01 |
| Caucasian-vs-AfricanAmerican |
4.183800E-01 |
| Caucasian-vs-Asian |
8.484200E-01 |
| AfricanAmerican-vs-Asian |
6.461400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.114300E-02 |
| Normal-vs-Female |
1.578970E-01 |
| Male-vs-Female |
3.754800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.392980E-01 |
| Normal-vs-Age(41-60Yrs) |
1.700040E-01 |
| Normal-vs-Age(61-80Yrs) |
1.339570E-01 |
| Normal-vs-Age(81-100Yrs) |
5.604000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.802200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.599800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.187800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.481200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.523800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.346800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.079100E-03 |
| Classical-VS-Follicular |
1.04729999994557E-06 |
| Classical-VS-Other |
2.788200E-01 |
| Classical-VS-Normal |
7.323000E-01 |
| Tall-VS-Follicular |
7.59450002885131E-09 |
| Tall-VS-Other |
1.673660E-02 |
| Tall-VS-Normal |
5.215800E-02 |
| Follicular-VS-Other |
4.453200E-01 |
| Follicular-VS-Normal |
1.71710999999908E-05 |
| Other-VS-Normal |
1.810040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.357400E-03 |
| Normal-vs-N1 |
1.679010E-01 |
| N0-vs-N1 |
5.181400E-01 |
|
|
